Search for other papers by André Marques-Pinto in
Google Scholar
PubMed
Serviço de Endocrinologia, Departamento de Endocrinologia, Faculdade de Medicina da Universidade do Porto, Al. Prof. Hernâni Monteiro, 4200-319 Porto, Portugal
Search for other papers by Davide Carvalho in
Google Scholar
PubMed
testicular dysgenesis syndrome There is an epidemiological correspondence between lower semen quality and higher incidences of cryptorchidism, hypospadias and testicular cancer (116) . These disorders have been regrouped as the testicular dysgenesis syndrome
Search for other papers by Tristan Avril in
Google Scholar
PubMed
Search for other papers by Quentin Hennocq in
Google Scholar
PubMed
Search for other papers by Anne-Sophie Lambert in
Google Scholar
PubMed
Université Paris Cité, Faculté de Santé, UFR de Médecine, Paris, France
Search for other papers by Juliane Leger in
Google Scholar
PubMed
Search for other papers by Dominique Simon in
Google Scholar
PubMed
Université Paris Cité, Faculté de Santé, UFR de Médecine, Paris, France
Inserm UMR1185, Le Kremlin Bicetre, Paris, France
Search for other papers by Laetitia Martinerie in
Google Scholar
PubMed
Inserm UMR1185, Le Kremlin Bicetre, Paris, France
Paris-Saclay University, Paris, France
Search for other papers by Claire Bouvattier in
Google Scholar
PubMed
cryptorchidism ( 1 ). It can be isolated or part of a combined pituitary hormone deficiency (CPHD) ( 2 ) and is usually in relation to a dysfunction in gonadotropin-releasing hormone (GnRH) secretion or action. The major clinical consequences of CHH are pubertal
Search for other papers by Bruno Donadille in
Google Scholar
PubMed
Search for other papers by Muriel Houang in
Google Scholar
PubMed
Université Pierre et Marie Curie, Sorbonne Université, Paris, France
Search for other papers by Irène Netchine in
Google Scholar
PubMed
INSERM UMR_S933, Paris, France
Search for other papers by Jean-Pierre Siffroi in
Google Scholar
PubMed
Université Pierre et Marie Curie, Sorbonne Université, Paris, France
INSERM UMR_S933, Paris, France
Search for other papers by Sophie Christin-Maitre in
Google Scholar
PubMed
Spermogram was reported in a single publication, in a patient carrying a severe HSD3B2 mutation (A10E) ( 11 ). Although his puberty had been normal and he had no past history of cryptorchidism, azoospermia as well as testicular adrenal rests tumours (TART
Search for other papers by Zofia Kolesinska in
Google Scholar
PubMed
Search for other papers by James Acierno Jr in
Google Scholar
PubMed
Search for other papers by S Faisal Ahmed in
Google Scholar
PubMed
Search for other papers by Cheng Xu in
Google Scholar
PubMed
Search for other papers by Karina Kapczuk in
Google Scholar
PubMed
Search for other papers by Anna Skorczyk-Werner in
Google Scholar
PubMed
Search for other papers by Hanna Mikos in
Google Scholar
PubMed
Search for other papers by Aleksandra Rojek in
Google Scholar
PubMed
Search for other papers by Andreas Massouras in
Google Scholar
PubMed
Search for other papers by Maciej R Krawczynski in
Google Scholar
PubMed
Search for other papers by Nelly Pitteloud in
Google Scholar
PubMed
Search for other papers by Marek Niedziela in
Google Scholar
PubMed
supplementary data given at the end of this article), a condition that shares some clinical presentations with DSD (i.e. cryptorchidism or micropenis) to further study their contribution. Reference transcript numbers for all genes evaluated are noted in
Search for other papers by Iben Katinka Greiber in
Google Scholar
PubMed
Search for other papers by Casper P Hagen in
Google Scholar
PubMed
Search for other papers by Alexander Siegfried Busch in
Google Scholar
PubMed
Search for other papers by Mikkel Grunnet Mieritz in
Google Scholar
PubMed
Search for other papers by Lise Aksglæde in
Google Scholar
PubMed
Search for other papers by Katharina Main in
Google Scholar
PubMed
Search for other papers by Kristian Almstrup in
Google Scholar
PubMed
Search for other papers by Anders Juul in
Google Scholar
PubMed
persistent Müllerian duct syndrome (PMDS) often including bilateral cryptorchidism but otherwise normal virilization of external genitalia ( 7 ). In postnatal life, serum levels of AMH are high during childhood but decline rapidly during puberty when the
Search for other papers by Catarina I Gonçalves in
Google Scholar
PubMed
Search for other papers by José M Aragüés in
Google Scholar
PubMed
Search for other papers by Margarida Bastos in
Google Scholar
PubMed
Search for other papers by Luísa Barros in
Google Scholar
PubMed
Search for other papers by Nuno Vicente in
Google Scholar
PubMed
Search for other papers by Davide Carvalho in
Google Scholar
PubMed
Search for other papers by Manuel C Lemos in
Google Scholar
PubMed
) Mutations 1 II-3 M 18.5 Delayed puberty. Micropenis. Tanner stage 3. Testicular volume 3 mL Normal Surgery for right-sided cryptorchidism at age 1.5 years FSH 1.2 IU/mL (1.0–8.0); LH 0.5 IU/mL (0.7–7.2); total testosterone 0.20 ng
Department of Endocrinology, St James’s Hospital, Dublin, Ireland
Search for other papers by Agnieszka Pazderska in
Google Scholar
PubMed
Search for other papers by Yaasir Mamoojee in
Google Scholar
PubMed
Search for other papers by Satish Artham in
Google Scholar
PubMed
Search for other papers by Margaret Miller in
Google Scholar
PubMed
Department of Endocrinology, University of Manchester, Manchester, UK
Search for other papers by Stephen G Ball in
Google Scholar
PubMed
Department of Paediatric Endocrinology & Diabetes, Newcastle-upon-Tyne Hospitals, Newcastle upon Tyne, UK
Search for other papers by Tim Cheetham in
Google Scholar
PubMed
Endocrine Research Group, Institute of Genetic Medicine, University of Newcastle-upon-Tyne, Newcastle upon Tyne, UK
Search for other papers by Richard Quinton in
Google Scholar
PubMed
cryptorchidism, or any apubertal man in his third decade or beyond), feeding them into the DPQC pathway merely imposes unnecessary delays. Regimes envisaged and designed for teenagers with suspected CDP offer frustratingly slow progress for older CHH men, who
Search for other papers by Mikkel Andreassen in
Google Scholar
PubMed
Search for other papers by Anders Juul in
Google Scholar
PubMed
Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed
Search for other papers by Niels Jørgensen in
Google Scholar
PubMed
hypogonadism ( 16 ). Exclusion criteria were previous or ongoing treatment with testosterone or gonadotropins, onset of testosterone deficiency before puberty and testicular disease including cryptorchidism. Twenty patients were included in the study and 27
Search for other papers by Lukas Plachy in
Google Scholar
PubMed
Search for other papers by Petra Dusatkova in
Google Scholar
PubMed
Search for other papers by Klara Maratova in
Google Scholar
PubMed
Search for other papers by Shenali Anne Amaratunga in
Google Scholar
PubMed
Search for other papers by Dana Zemkova in
Google Scholar
PubMed
Search for other papers by Vit Neuman in
Google Scholar
PubMed
Search for other papers by Stanislava Kolouskova in
Google Scholar
PubMed
Search for other papers by Barbora Obermannova in
Google Scholar
PubMed
Search for other papers by Marta Snajderova in
Google Scholar
PubMed
Search for other papers by Zdenek Sumnik in
Google Scholar
PubMed
Search for other papers by Jan Lebl in
Google Scholar
PubMed
Search for other papers by Stepanka Pruhova in
Google Scholar
PubMed
anophtalmia, PMR, cryptorchidism 2.3 −4.4 −4.0 −3.1 −3.8 2 M 13.1 −1.7 1.1 CHT, CAI, HH Pituitary hyperplasia – 3.5 −3.4 −1.3 +0.3 +1.0 3 M 10.3 BDL 0.3 CHT NA Neonatal hypoglycaemia 1.1 −5.4 −3
Search for other papers by Pamela Stratton in
Google Scholar
PubMed
Search for other papers by Neelam Giri in
Google Scholar
PubMed
Search for other papers by Sonia Bhala in
Google Scholar
PubMed
Search for other papers by Martha M Sklavos in
Google Scholar
PubMed
Search for other papers by Blanche P Alter in
Google Scholar
PubMed
Search for other papers by Sharon A Savage in
Google Scholar
PubMed
Search for other papers by Ligia A Pinto in
Google Scholar
PubMed
. The use of AMH levels in males in clinical practice has not been defined and requires further study. Thus far, AMH levels appear to be useful in differentiating non-obstructive azoospermia from obstructive azoospermia, anorchidism from cryptorchidism